ESAB
ESAB
$71.46
+2.23%
ESAB Corporation is a leading manufacturer of welding, cutting, and joining equipment and consumables, spun off from Colfax in 2022 and operating in the industrial metal fabrication space. Alongside Lincoln Electric and ITW's Miller brand, ESAB is one of the top three global players in welding, with roughly $2.8 billion in revenue and a portfolio spanning equipment (the dominant revenue line at approximately $1.41 billion) and consumables. The current investor narrative is dominated by a sharp deterioration in sentiment: the stock has fallen roughly 35% over the past year and is down about 36% year-to-date, with the most recent quarterly results showing margin compression (gross margin fell to 30.5% in Q4 2025 from 38.5% a year earlier) and a steep sequential decline in net income. Despite the price collapse, sell-side analysts remain overwhelmingly constructive, with a consensus rating of strong buy and an average target price implying substantial upside, creating an unusual divergence between market pricing and analyst expectations. The debate centers on whether the recent weakness reflects a cyclical industrial slowdown, integration/restructuring costs, or a genuine structural impairment of the franchise.…
ESAB
ESAB
$71.46
Investment Opinion: Should I buy ESAB Today?
Synthesized rating: Hold with a speculative buy bias for risk-tolerant investors. The core thesis is that ESAB's 36% YTD decline has priced in a severe earnings downturn, yet the company still generates $213 million in trailing free cash flow and trades at 11.1x forward earnings, while analysts maintain a strong buy consensus with a $126.91 average target. However, the Q4 gross margin collapse to 30.5% and 30% YoY EPS decline are red flags that cannot be ignored until there is evidence of stabilization.
The supporting evidence for a constructive view includes: (1) forward PE of 11.1x versus trailing PE of 30.0x, implying the market expects a sharp earnings recovery; (2) revenue growth of 7.5% YoY in Q4 2025, showing demand is not collapsing; (3) free cash flow of $213.3 million TTM, which covers the modest dividend (yield 0.32%) nearly 30 times over; and (4) the average analyst target of $126.91 implies 76% upside, with even the low target of $100 offering 39% upside. The current ratio of 1.90 and debt-to-equity of 0.66 suggest the balance sheet can withstand a downturn.
The biggest risks that could invalidate this thesis are: (1) further gross margin deterioration below 30%, which would call into question the forward EPS estimates; (2) a broader industrial recession that reduces equipment demand and delays a margin recovery; and (3) competitive share loss to Lincoln Electric or Miller. The rating would upgrade to Buy if gross margin stabilizes above 33% for two consecutive quarters or if forward EPS estimates are revised upward. It would downgrade to Sell if gross margin falls below 28% or if revenue growth turns negative. On valuation, ESAB appears undervalued relative to its own history and analyst targets, but the market is pricing in a high degree of uncertainty, so the stock is fairly valued until margin visibility improves.
Sign up to view all
ESAB 12-Month Price Forecast
ESAB presents a classic value-versus-momentum conflict: the stock is deeply oversold with a 36% YTD decline, yet analysts remain overwhelmingly bullish and the forward valuation is undemanding at 11.1x earnings. The critical unknown is whether the Q4 gross margin collapse is a temporary trough or a structural impairment; until this is resolved, the risk/reward is balanced but skewed positive for patient investors. I would upgrade to bullish if gross margin recovers above 33% in the next two quarters, and downgrade to bearish if it falls below 28% or if revenue growth turns negative. The high short ratio and low expectations create potential for a sharp rebound on any positive surprise, but the lack of near-term catalysts and negative momentum warrant caution.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on ESAB's 12-month outlook, with a consensus price target around $126.91 and implied upside of +77.6% versus the current price.
Average Target
$126.91
0 analysts
Implied Upside
+77.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$100 - $145
Analyst target range
Bulls vs Bears: ESAB Investment Factors
The bear case currently has stronger near-term evidence: gross margin collapsed 800bps YoY, EPS fell 30% YoY, and the stock is down 36% YTD with deeply negative relative strength. However, the bull case rests on a compelling valuation disconnect — 11.1x forward earnings, a strong buy consensus, and a $126.91 average target implying 76% upside — that suggests the market may be over-penalizing a cyclical margin trough. The single most important tension is whether the Q4 gross margin decline is a temporary cost/mix issue that normalizes in 2026, or the beginning of structural margin erosion; if it is the former, the stock is deeply undervalued, and if the latter, analysts are badly mispriced.
Bullish
- Analyst consensus strong buy with 76% upside: All 11 covering analysts rate ESAB a strong buy (recommendation mean 1.27), with an average target price of $126.91 versus the current $71.91 — implying roughly 76% upside. Even the lowest analyst target of $100 sits 39% above the current price, suggesting the sell-side views the recent collapse as disconnected from fundamental value.
- Forward PE of 11.1x is deeply discounted: ESAB trades at just 11.1x forward earnings based on estimated EPS of $9.86, a steep discount to the broader industrial sector and its own trailing PE of 30.0x. This compression reflects a market pricing in severe earnings deterioration that analysts do not forecast, creating a potential valuation re-rating opportunity if results stabilize.
- Revenue still growing at 7.5% YoY: Despite margin pressure, Q4 2025 revenue of $721.0 million grew 7.5% year-over-year, and full-year 2025 revenue of approximately $2.84 billion exceeded the prior year. The top line remains resilient, indicating the issue is cost/margin-related rather than demand destruction.
- Strong FCF generation and healthy balance sheet: ESAB generated $213.3 million in trailing free cash flow and maintains a current ratio of 1.90 with a manageable debt-to-equity of 0.66. This provides ample liquidity to fund restructuring, dividends, and potential buybacks without balance-sheet stress.
Bearish
- Gross margin collapsed 800bps YoY: Q4 2025 gross margin fell to 30.5% from 38.5% in Q4 2024, an 800 basis point deterioration. This is the most alarming data point, as it suggests either severe pricing pressure, unfavorable mix, or unanticipated cost inflation that is eroding the core profitability of the franchise.
- Net income and EPS decelerated sharply: Q4 2025 net income fell to $37.7 million (EPS $0.55) from $53.7 million (EPS $0.88) a year earlier, a 30% decline. The sequential drop from Q3's $54.8 million (EPS $0.90) was even steeper, indicating a rapid deterioration in earnings power that the market is correctly discounting.
- Severe underperformance versus S&P 500: ESAB's relative strength versus the S&P 500 is -51.8% over one year and -49.2% YTD, with the S&P up 17.2% and 13.1% respectively over those periods. This extreme divergence signals that investors are aggressively rotating out of the name, and the momentum remains deeply negative.
- Trailing PE of 30x on collapsing earnings: The trailing PE of 30.0x is expensive for a company with declining earnings and a 0.03 EPS. If forward estimates prove too optimistic — as the Q4 miss suggests — the stock could be far more expensive than the 11.1x forward multiple implies, leaving room for further downside.
ESAB Technical Analysis
Beta
1.14
1.14x market volatility
Max Drawdown
-51.8%
Largest decline past year
52-Week Range
$65-$137
Price range past year
Annual Return
-39.2%
Cumulative gain past year
| Period | ESAB Return | S&P 500 |
|---|---|---|
| 1m | -4.7% | +0.6% |
| 3m | -24.0% | +3.6% |
| 6m | -30.6% | +14.6% |
| 1y | -39.2% | +15.8% |
| ytd | -36.5% | +13.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ESAB Fundamental Analysis
Quarterly Revenue
$720986000.0B
2025-12
Revenue YoY Growth
+7.5%
YoY Comparison
Gross Margin
30.5%
Latest Quarter
Free Cash Flow
$213280000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ESAB Overvalued?
PE
30.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 10x~45x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.4x
Enterprise Value Multiple
Investment Risk Disclosure
ESAB's financial risk profile is dominated by the sharp margin deterioration: Q4 2025 gross margin fell to 30.5% from 38.5% a year earlier, while net income dropped 30% YoY to $37.7 million. The company carries $0.66 of debt per dollar of equity and a current ratio of 1.90, which is adequate but not fortress-like, and interest expense of $17.9 million in Q4 alone consumes a meaningful share of operating income. With trailing EPS of just $0.03 and a payout ratio of 9.7%, the dividend is small but the earnings base is thin, leaving little cushion if margins compress further. The dependence on equipment sales (~$1.41 billion of revenue) ties performance to capital spending cycles, and any sustained demand weakness would pressure both revenue and profitability simultaneously.
Market and competitive risks are elevated by ESAB's premium valuation relative to its own history and the industrial sector. The trailing PE of 30.0x and price-to-book of 3.14x are rich for a company with declining earnings, and the forward PE of 11.1x relies on analyst EPS estimates of $9.86 that appear increasingly optimistic given the Q4 miss. ESAB competes with Lincoln Electric and ITW's Miller brand in a consolidated but price-competitive welding market, and share loss or pricing pressure could accelerate margin erosion. The stock's beta of 1.13 means it amplifies market moves, and with the S&P 500 up 17.2% over the past year while ESAB fell 34.6%, the relative strength of -51.8% highlights severe underperformance that could persist if industrial sentiment remains weak. Recent news of geopolitical risk reduction (Hormuz reopening) is a modest positive for macro sentiment but does little to address company-specific issues.
The worst-case scenario for ESAB would be a continued decline in gross margin toward the low-20s, driven by pricing pressure and unfavorable mix, combined with a slowdown in industrial capex that reduces equipment demand. In that scenario, forward EPS estimates of $9.86 would be cut sharply, and the stock could retest its 52-week low of $64.83 — an additional 9.8% downside from the current $71.91. If the bear case fully materializes and the stock breaks below the 52-week low, the next support could be in the $55–60 range, implying a 17–24% loss from current levels. The maximum drawdown over the past year was already -51.8%, so a further 20% decline is well within the realm of possibility if earnings continue to disappoint.
FAQ
The most severe risk is continued gross margin erosion; Q4 2025 gross margin fell to 30.5% from 38.5%, and further declines would invalidate the earnings recovery thesis. Second, industrial cyclicality: with a beta of 1.13, ESAB is sensitive to manufacturing slowdowns, and a recession could cut equipment demand. Third, competitive pressure from Lincoln Electric and Miller could force price concessions. Fourth, execution risk on restructuring and integration could keep costs elevated. Finally, the stock's negative momentum and -51.8% relative strength versus the S&P 500 could persist, leading to further underperformance.
Our 12-month forecast has three scenarios: bull case (25% probability) targeting $126–145 if margins recover and EPS hits $9.86; base case (50% probability) targeting $95–115 with modest margin stabilization and EPS around $8.50–9.00; and bear case (25% probability) targeting $55–65 if margins fall below 28% and industrial demand weakens. The base case is most likely, implying a potential return of 32–60% from the current $71.91. The key assumption is that gross margin stabilizes in the low-30s by mid-2026.
ESAB appears undervalued on forward earnings (11.1x) but expensive on trailing earnings (30.0x) and price-to-book (3.14x). The market is pricing in a sharp earnings recovery that has not yet materialized, as evidenced by the Q4 miss. Relative to its own history, the forward multiple is near multi-year lows, suggesting the stock is discounting a severe downturn. If forward EPS of $9.86 is achieved, the stock is deeply undervalued; if estimates are cut to $7–8, it is fairly valued. The truth likely lies in between, making the stock modestly undervalued with high uncertainty.
ESAB is a high-risk, high-reward contrarian buy candidate. The stock trades at $71.91, down 36% YTD, with a forward PE of 11.1x and an average analyst target of $126.91 implying 76% upside. However, the Q4 2025 gross margin collapse to 30.5% and 30% YoY EPS decline are serious concerns that could persist. For risk-tolerant investors with a 2–3 year horizon, the risk/reward is attractive, but conservative investors should wait for evidence of margin stabilization before committing capital.
ESAB is better suited for long-term investors with a 2–3 year horizon who can tolerate volatility, as the turnaround thesis requires time for margin recovery and earnings normalization. The stock's beta of 1.13 and 51.8% max drawdown make it unsuitable for short-term traders seeking stability. The dividend yield is negligible at 0.32%, so returns depend on capital appreciation. A minimum holding period of 18–24 months is advisable to allow the cyclical recovery to play out. Short-term trading could be opportunistic around earnings, but the risk of further downside is significant.